Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update

被引:155
|
作者
Dale, William [1 ]
Klepin, Heidi D. [2 ]
Williams, Grant R. [3 ]
Alibhai, Shabbir M. H. [4 ]
Bergerot, Cristiane [5 ]
Brintzenhofeszoc, Karlynn [6 ]
Hopkins, Judith O. [7 ]
Jhawer, Minaxi P. [8 ]
Katheria, Vani [9 ]
Loh, Kah Poh [10 ]
Lowenstein, Lisa M. [11 ]
Mckoy, June M. [12 ]
Noronha, Vanita [13 ]
Phillips, Tanyanika [14 ]
Rosko, Ashley E. [15 ]
Ruegg, Tracy [16 ]
Schiaffino, Melody K. [17 ]
Simmons, John F. [18 ]
Subbiah, Ishwaria [19 ]
Tew, William P. [20 ]
Webb, Tracy L. [21 ]
Whitehead, Mary [22 ]
Somerfield, Mark R. [23 ]
Mohile, Supriya G. [10 ,24 ]
机构
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Wake Forest Baptist Comprehens Canc Ctr, Winston Salem, NC USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] CETTRO Canc Res Hosp Brasilia, Brasilia, Brazil
[6] Univ Louisville, Kent Sch Social Work, Louisville, KY USA
[7] SCOR NCORP, Novant Hlth Canc Inst, Winston Salem, NC USA
[8] Englewood Hlth, Englewood, NJ USA
[9] City Hope Comprehens Canc Ctr, Duarte, CA USA
[10] Univ Rochester, Med Ctr, Rochester, NY USA
[11] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[12] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[13] Tata Mem Hosp, Mumbai, India
[14] City Hope Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
[15] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[16] Kennesaw State Univ, WellStar Sch Nursing, Kennesaw, GA USA
[17] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
[18] SCOREboard, Oakland, CA USA
[19] MD Anderson Canc Ctr, Houston, TX USA
[20] Mem Sloan Kettering Canc Ctr, New York, NY USA
[21] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[22] SCOREboard, Sharon, CT USA
[23] Amer Soc Clin Oncol, Alexandria, VA USA
[24] Amer Soc Clin Oncol, 2318 Mill Rd, Suite 800, Alexandria, VA 22314 USA
关键词
COMPREHENSIVE GERIATRIC ASSESSMENT; QUALITY-OF-LIFE; ADULTS AGED 65; CHEMOTHERAPY TOXICITY; AMERICAN SOCIETY; CLINICAL-TRIALS; GAIT SPEED; MINI-COG; SURVIVAL; VALIDATION;
D O I
10.1200/JCO.23.00933
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSETo update the ASCO guideline (2018) on the practical assessment and management of age-associated vulnerabilities in older patients undergoing systemic cancer therapy.METHODSAn Expert Panel conducted a systematic review to identify relevant randomized clinical trials (RCTs), systematic reviews, and meta-analyses from January 2016 to December 2022.RESULTSA total of 26 publications met eligibility criteria and form the evidentiary basis for the update.RECOMMENDATIONSThe Expert Panel reiterates its overarching recommendation from the prior guideline that geriatric assessment (GA), including all essential domains, should be used to identify vulnerabilities or impairments that are not routinely captured in oncology assessments for all patients over 65 years old with cancer. Based on recently published RCTs demonstrating significantly improved clinical outcomes, all older adults with cancer (65+ years old) receiving systemic therapy with GA-identified deficits should have GA-guided management (GAM) included in their care plan. GAM includes using GA findings to inform cancer treatment decision-making as well as to address impairments through appropriate interventions, counseling, and/or referrals. A GA should include high priority aging-related domains known to be associated with outcomes in older adults with cancer: physical and cognitive function, emotional health, comorbid conditions, polypharmacy, nutrition, and social support. Clinical adaptation of the GA based on patient population, resources, and time is appropriate.The Panel recommends the Practical Geriatric Assessment as one option for this purpose (https://old-prod.asco.org/sites/new-www.asco.org/files/content-files/practice-patients/documents/2023-PGA-Final.pdf; https://youtu.be/jnaQIjOz2Dw; https://youtu.be/nZXtwaGh0Z0).Additional information is available at www.asco.org/supportive-care-guidelines.RECOMMENDATIONSThe Expert Panel reiterates its overarching recommendation from the prior guideline that geriatric assessment (GA), including all essential domains, should be used to identify vulnerabilities or impairments that are not routinely captured in oncology assessments for all patients over 65 years old with cancer. Based on recently published RCTs demonstrating significantly improved clinical outcomes, all older adults with cancer (65+ years old) receiving systemic therapy with GA-identified deficits should have GA-guided management (GAM) included in their care plan. GAM includes using GA findings to inform cancer treatment decision-making as well as to address impairments through appropriate interventions, counseling, and/or referrals. A GA should include high priority aging-related domains known to be associated with outcomes in older adults with cancer: physical and cognitive function, emotional health, comorbid conditions, polypharmacy, nutrition, and social support. Clinical adaptation of the GA based on patient population, resources, and time is appropriate.The Panel recommends the Practical Geriatric Assessment as one option for this purpose (https://old-prod.asco.org/sites/new-www.asco.org/files/content-files/practice-patients/documents/2023-PGA-Final.pdf; https://youtu.be/jnaQIjOz2Dw; https://youtu.be/nZXtwaGh0Z0).Additional information is available at www.asco.org/supportive-care-guidelines. RECOMMENDATIONSThe Expert Panel reiterates its overarching recommendation from the prior guideline that geriatric assessment (GA), including all essential domains, should be used to identify vulnerabilities or impairments that are not routinely captured in oncology assessments for all patients over 65 years old with cancer. Based on recently published RCTs demonstrating significantly improved clinical outcomes, all older adults with cancer (65+ years old) receiving systemic therapy with GA-identified deficits should have GA-guided management (GAM) included in their care plan. GAM includes using GA findings to inform cancer treatment decision-making as well as to address impairments through appropriate interventions, counseling, and/or referrals. A GA should include high priority aging-related domains known to be associated with outcomes in older adults with cancer: physical and cognitive function, emotional health, comorbid conditions, polypharmacy, nutrition, and social support. Clinical adaptation of the GA based on patient population, resources, and time is appropriate.The Panel recommends the Practical Geriatric Assessment as one option for this purpose (https://old-prod.asco.org/sites/new-www.asco.org/files/content-files/practice-patients/documents/2023-PGA-Final.pdf; https://youtu.be/jnaQIjOz2Dw; https://youtu.be/nZXtwaGh0Z0).Additional information is available at www.asco.org/supportive-care-guidelines.
引用
收藏
页码:4293 / +
页数:22
相关论文
共 50 条
  • [41] Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and A
    Al Sukhun, Sana
    Koczwara, Bogda
    Temin, Sarah
    Arun, Banu K.
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [42] Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline
    Peterson, Douglas E.
    Koyfman, Shlomo A.
    Yarom, Noam
    Lynggaard, Charlotte Duch
    Ismaila, Nofisat
    Forner, Lone E.
    Fuller, Clifton David
    Mowery, Yvonne M.
    Murphy, Barbara A.
    Watson, Erin
    Yang, David H.
    Alajbeg, Ivan
    Bossi, Paolo
    Fritz, Michael
    Futran, Neal D.
    Gelblum, Daphna Y.
    King, Edward
    Ruggiero, Salvatore
    Smith, Derek K.
    Villa, Alessandro
    Wu, Jonn S.
    Saunders, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16) : 1975 - 1996
  • [43] Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A
    Garje, Rohan
    Hope, Thomas A.
    Rumble, R. Bryan
    Parikh, Rahul A.
    JCO ONCOLOGY PRACTICE, 2023, 19 (03) : 132 - +
  • [45] Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
    Hwang, Jessica P.
    Feld, Jordan J.
    Hammond, Sarah P.
    Wang, Su H.
    Alston-Johnson, Devena E.
    Cryer, Donna R.
    Hershman, Dawn L.
    Loehrer, Andrew P.
    Sabichi, Anita L.
    Symington, Banu E.
    Terrault, Norah
    Wong, Melisa L.
    Somerfield, Mark R.
    Artz, Andrew S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (31) : 3698 - +
  • [46] Assessment of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Systemic Therapy
    Farrukh, Nida
    Bano, Razia
    Naqvi, Syeda Rifaat Qamar
    Latif, Humera
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 746 - 750
  • [47] Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline
    Khurshid, Humera
    Ismaila, Nofisat
    Bian, Jessica
    Dabney, Raetasha
    Das, Millie
    Ellis, Peter
    Feldman, Jill
    Hann, Christine
    Kulkarni, Swati
    Laskin, Janessa
    Manochakian, Rami
    Mishra, Deebya Raj
    Preeshagul, Isabel
    Reddy, Pavan
    Saxena, Ashish
    Weinberg, Frank
    Kalemkerian, Gregory P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (35) : 5448 - +
  • [48] Detection and management of hyperglycaemia in oncology patients receiving systemic anti-cancer therapy
    Morrison, L.
    Gillmore, R.
    Pierce, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [49] Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
    Singh, Navneet
    Daly, Megan E.
    Ismaila, Nofisat
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (27) : 4430 - +
  • [50] Poly(ADP-Ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update
    Tew, William P.
    Lacchetti, Christina
    Kohn, Elise C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (33) : 3878 - +